Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
Atherosclerosis|November 6, 2009
Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variationKlelia D Salpea, Philippa J Talmud, Jackie A Cooper, et al.
Human Molecular Genetics|November 6, 2002
Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglyceridesPhilippa J Talmud, Emma Hawe, Steve Martin, et al.
Atherosclerosis|October 19, 2004
No APOEepsilon4 effect on coronary heart disease risk in a cohort with low smoking prevalence: the Whitehall II studyPhilippa J Talmud, Sarah J Lewis, Emma Hawe, et al.
Human Molecular Genetics|June 4, 2004
Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study IIWendy Putt, Jutta Palmen, Viviane Nicaud, et al.
Clinical Chemistry and Laboratory Medicine|July 8, 2008
APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levelsJaroslav A Hubacek, Wu-Wei Wang, Zdena Skodová, et al.
Atherosclerosis|January 23, 2016
Post-GWAS methodologies for localisation of functional non-coding variants: ANGPTL3Federico Oldoni, Jutta Palmen, Claudia Giambartolomei, et al.
BMJ (Clinical Research Ed.)|January 16, 2010
Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort studyPhilippa J Talmud, Aroon D Hingorani, Jackie A Cooper, et al.
Human Heredity|August 7, 2004
Evidence of admixture from haplotyping in an epidemiological study of UK Caucasian males: implications for association analysesXiao-he Chen, Santiago Rodríguez, Emma Hawe, et al.
Circulation Research|April 5, 2003
Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levelsWai-man R Wong, Emma Hawe, Lai K Li, et al.
Atherosclerosis|March 16, 2015
APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosisMontse Guardiola, Montserrat Cofán, Isabel de Castro-Oros, et al.
Pageof 13